健康权益
HQY
92.03
-0.48
-0.52%
健康权益
US · HQY
#1726 按市值排名
上市于 1970
92.03
-0.48
-0.52%
实时 - 追踪5344个代码 - 心跳于427秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了5家。
- 机构持股总比例上升了0.5个百分点。
机构持股
- 机构持股比例
- 110.40% +0.51pp
- 机构数量
- 591 -5
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund92.44%
Hedge Fund8.79%
Public Company3.32%
Private Company2.46%
Individual/Insider1.99%
Government Pension Fund1.70%
Sovereign Wealth Fund0.69%
Family Office/Trust0.49%
Insurance Company0.44%
主要股东 截至 2026-06-30
BlackRock
13.63% · 11.28M 股
Wasatch Advisors LP
9.62% · 7.96M 股
Vanguard Capital Management, LLC
5.13% · 4.24M 股
Vanguard Portfolio Management, LLC
4.91% · 4.06M 股
State Street Global Advisors
3.92% · 3.24M 股
Eaton Vance Management
2.94% · 2.43M 股
Geode Capital Management, LLC
2.87% · 2.37M 股
AQR Capital Management
2.41% · 1.99M 股
Dimensional Fund Advisors
2.26% · 1.87M 股
William Blair Investment Management, LLC
2.21% · 1.83M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 20次买入 · 27次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Stephen Neeleman | Founder & Vice Chairman | 1.03% |
| Jon Kessler | Chief Executive Officer | 0.40% |
| Robert Selander | Independent Non-Executive Chairperson | 0.11% |
| Elimelech Rosner | Former Chief Technology Officer | 0.10% |
| Adrian Dillon | Independent Director | 0.07% |
| Delano Ladd | General Counsel | 0.07% |
| Evelyn Dilsaver | Independent Director | 0.06% |
| James Lucania | Chief Financial Officer | 0.04% |
| Stuart Parker | Independent Director | 0.03% |
| Scott Cutler | Chief Executive Officer | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-23 | Noemie Heuland | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-09-16 | Stephen Neeleman | Founder & Vice Chairman | Other Disposition | -1,500 | -- |
| 2026-08-24 | Adrian Dillon | Independent Director | Derivative Exercise and Sale | -7,632 | $32.50–105.26 |
| 2026-07-09 | Michael Fiore | Executive Vice President | Open Market Disposition | -2,354 | $95.00 |
| 2026-07-08 | Michael Gathright | -- | Sale to Issuer | -2,270 | $93.07 |
| 2026-07-07 | James Lucania | Chief Financial Officer | Sale to Issuer | -2,839 | $95.08 |
| 2026-07-07 | Stephen Neeleman | Founder & Vice Chairman | Sale to Issuer | -1,103 | $95.08 |
| 2026-07-07 | Scott Cutler | Chief Executive Officer | Sale to Issuer | -1,238 | $95.08 |
| 2026-07-07 | Delano Ladd | General Counsel | Sale to Issuer | -1,087 | $95.08 |
| 2026-07-07 | Michael Fiore | Executive Vice President | Sale to Issuer | -2,045 | $95.08 |
| 2026-07-01 | Michael Fiore | Executive Vice President | Automatic Disposition | -2,470 | $95.00 |
| 2026-06-24 | Adrian Dillon | Independent Director | Other Acquisition | +2,877 | -- |
| 2026-06-24 | Robert Selander | Independent Non-Executive Chairperson | Other Acquisition | +2,877 | -- |
| 2026-06-24 | Evelyn Dilsaver | Independent Director | Other Acquisition | +2,877 | -- |
| 2026-06-24 | Stuart Parker | Independent Director | Other Acquisition | +2,877 | -- |
| 2026-06-24 | Gayle Wellborn | Independent Director | Other Acquisition | +2,877 | -- |
| 2026-06-24 | Debra McCowan | Independent Director | Other Acquisition | +2,877 | -- |
| 2026-06-24 | Rajesh Natarajan | Independent Director | Other Acquisition | +2,877 | -- |
| 2026-06-24 | William Gassen | Director | Other Acquisition | +2,877 | -- |
| 2026-05-28 | Michael Fiore | Executive Vice President | Automatic Disposition | -3,142 | $95.00 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
健康权益 讨论区 0 条评论